key: cord-0773652-i03wmhsd authors: Alizon, Samuel; Haim-Boukobza, Stéphanie; Foulongne, Vincent; Verdurme, Laura; Trombert-Paolantoni, Sabine; Lecorche, Emmanuel; Roquebert, Bénédicte; Sofonea, Mircea T. title: Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021 date: 2021-07-15 journal: Euro Surveill DOI: 10.2807/1560-7917.es.2021.26.28.2100573 sha: 3a9ddd5d15f45eb12ec94dfbe6ebe629f5dcdc84 doc_id: 773652 cord_uid: i03wmhsd We analysed 9,030 variant-specific RT-PCR tests performed on SARS-CoV-2-positive samples collected in France between 31 May and 21 June 2021. This analysis revealed rapid growth of the Delta variant in three of the 13 metropolitan French regions and estimated a +79% (95% confidence interval: 52–110%) transmission advantage compared with the Alpha variant. The next weeks will prove decisive and the magnitude of the estimated transmission advantages of the Delta variant could represent a major challenge for public health authorities. All the other combinations were rare and grouped in the "other" category (see below for the details). The data was extracted on June 28, 2021 and the most recent test results were from June 26, 2021. However, to correct for potential delays in the recording of the results from local partners, we did not include any tests performed after June 21, 2021. We also only included from individuals from 5 to 80 years old, and included at most one sample per individual. The statistical methods are described in details in [1] . The data and R script used will be provided upon publication. The characteristics of the data are shown in Table S1 . Among the`other' test results, the majority corresponded to uninterpretable test results (751/1394, i.e. 54%) and a large fraction to tests without the L452R mutant and an ambiguity for the E484 mutation (524/1394, i.e. 38%), which could be indicative of an infected by a β, γ, or η variant with a low virus load. Note that this assumption is conservative to avoid overestimating the spread of the δ variant. In fact, some of the tests in the`other' category (74/1394, i.e. 5%) nd a clear signal for the L452R mutation with an ambiguity regarding the E484 mutation and could, therefore, be associated with this variant. The epidemiological model used to simulate the scenarios shown in Figure 2 is based on the discretetimeframework adjusted to the French epidemic the methodology of which is detailed in [2] . The original model was extended to take into account the vaccine rollout, the extrapolation of which was based the trend observed by the of June. We made the simplifying (and optimistic) assumption that the vaccine prevents 90% of critical infections and 80% of secondary infections directly from the rst dose injection, while we assumed natural immunity to prevent 84% of reinfections [3] , regardless of the virus genotype. The modelled spread of the δ variant was based on a initial 25%-frequency on Jun 29th and a 70% transmission advantage compared to the α variant, assumed itself to have a 40% transmission advantage with respect to the historical strain [1] . The SARS-CoV-2 B.1.351 lineage (VOC β) is outgrowing the B.1.1.7 lineage (VOC α) in some French regions in Memory is key in capturing COVID-19 epidemiological dynamics SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN). The Lancet